Creates provisions relating to testing for diagnosis of uterine cancer

Summary

The bill mandates that any abnormal tissue sample taken from the uterine lining be tested for p53 protein abnormalities. This additional test is required alongside any other diagnostic tests. It aims to improve the accuracy of diagnosing and treating uterine cancer.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share